Lupin buys two inhalation brands from Sunovion Pharma for $75 M
To expand Lupin's portfolio of inhalation products in the US
Stay updated with breaking news from Inhalation Solution. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
To expand Lupin's portfolio of inhalation products in the US
(RTTNews) - United Therapeutics Corp. (UTHR) said that it has prevailed in dry powder inhaler patent litigation with Liquidia Technologies. Unite...
03.08.2022 - United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced its financial results for the quarter ended June 30, 2022. Total revenues in the second quarter of 2022 grew 5% year-over-year to $466.9 million, compared ...
Tyvaso DPI represents the second FDA-approved product utilizing MannKind’s Technosphere® inhalation technologyFirst approval of a dry powder inhaled...
Press release content from Accesswire. The AP news staff was not involved in its creation.